GSK
GlaxoSmithKline PLC ADR
NYSE: GSK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$52.31
+1.77% today
Updated 2026-04-30
Market cap
$104.41B
P/E ratio
13.62
P/S ratio
3.19x
EPS (TTM)
$3.84
Dividend yield
3.44%
52W range
$34 – $61
Volume
4.7M
GlaxoSmithKline PLC ADR (GSK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $27.20B | $25.55B | $31.00B | $39.39B | $42.86B | $42.05B | $41.08B | $41.48B | $42.09B | $40.65B | $53.45B | $59.08B | $56.38B | $58.07B | $105.57B | $109.95B | $107.14B | $60.15B | $75.22B | $59.46B |
| Cash & equivalents | $4.21B | $2.00B | $3.38B | $5.62B | $6.54B | $6.06B | $5.71B | $4.18B | $5.53B | $4.34B | $5.83B | $4.90B | $3.83B | $3.87B | $6.24B | $8.60B | $5.79B | $3.72B | $3.74B | $3.69B |
| Current assets | $13.18B | $10.99B | $13.63B | $17.27B | $17.57B | $16.04B | $16.17B | $13.69B | $15.23B | $14.68B | $16.59B | $16.71B | $15.91B | $16.93B | $25.82B | $27.68B | $25.29B | $20.77B | $23.77B | $17.00B |
| Total liabilities | $19.63B | $15.90B | $21.09B | $31.07B | $32.12B | $32.31B | $32.25B | $34.73B | $34.27B | $35.72B | $44.57B | $54.12B | $52.89B | $54.39B | $81.25B | $81.50B | $78.23B | $50.05B | $58.91B | $46.38B |
| Current liabilities | $9.51B | $7.26B | $10.35B | $10.02B | $12.12B | $12.62B | $15.01B | $13.81B | $13.68B | $13.29B | $13.42B | $19.00B | $26.57B | $22.49B | $31.86B | $30.28B | $32.06B | $22.81B | $26.86B | $21.70B |
| Long-term debt | $9.06B | $9.35B | $14.02B | $22.27B | $23.90B | $22.79B | $18.96B | $23.86B | $25.62B | $24.68B | $15.28B | $14.62B | $14.22B | $20.23B | $22.58B | $23.43B | $20.57B | $17.04B | $14.15B | $13.70B |
| Shareholder equity | $7.31B | $9.39B | $9.60B | $7.93B | $10.01B | $8.89B | $8.03B | $5.81B | $7.00B | $4.26B | $5.11B | $1.12B | $-68.00M | $4.36B | $15.11B | $19.94B | $20.39B | $10.60B | $17.01B | $13.67B |
| Retained earnings | $5.58B | $6.96B | $6.47B | $4.62B | $6.32B | $4.78B | $3.37B | $652.00M | $913.00M | $-2.07B | $-1.40B | $-5.39B | $-6.48B | $-2.14B | $8.45B | $11.76B | $13.26B | $4.36B | $9.23B | $7.80B |
| Accounts receivable | $2.03M | $5.28B | $5.31B | $6.05B | $6.25B | $5.59B | $5.32B | $5.06B | $5.28B | $4.49B | $3.88B | $5.92B | $5.95B | $6.32B | $9.47B | $9.93B | $10.88B | $6.22B | $9.44B | $6.00B |
| Inventory | $2.18B | $2.44B | $3.06B | $4.06B | $4.06B | $3.84B | $3.87B | $3.97B | $3.90B | $4.23B | $4.72B | $5.10B | $5.56B | $5.48B | $7.88B | $8.20B | $7.83B | $5.15B | $7.01B | $5.67B |
| Goodwill | $696.00M | $758.00M | $1.37B | $2.10B | $3.36B | $3.61B | $3.75B | $4.36B | $4.21B | $3.72B | $5.16B | $5.96B | $5.73B | $5.79B | $13.99B | $14.49B | $14.29B | $7.05B | $8.68B | $6.98B |